HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


House And Senate Farm Bills Dilemma: Each Includes One, But Not Both Of Supplement Industry's SNAP, Hemp Goals

This article was originally published in The Rose Sheet

Executive Summary

Senate's USDA five-year reauthorization would remove hemp from federal list of controlled substances and lift limits on production in the US but does not contain language included in the House bill to make multivitamins eligible for Supplemental Nutrition Assistance Program purchases. House bill though, doesn't clear hemp production. "I think we have a lot of work of ahead of us on both fronts," says CRN President and CEO Steve Mister.


Related Content

Farm Bill Would Boost USDA Organic Program Funding, Supply Chain Safety
Hemp Product Market Future Backed By McConnell, Fate Depends On Farm Bill
Adding Multivitamins To SNAP Sprouts Or Wilts In Congress' Decision On Farm Bill
CBD Drug Approval Not A Sign FDA Will Allow Its Use In Supplements
It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims
'Big Shoes To Fill' As Hatch Retirement Leaves Supplement Market Legacy
Making Nutritionals Eligible For Health Savings Accounts Whets Congress' Appetite





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts